Personal and Prognostic: Tissue and Liquid Biomarkers of Radiotherapeutic Response in Non-Small Cell Lung Cancer.

Personal and Prognostic: Tissue and Liquid Biomarkers of Radiotherapeutic Response in Non-Small Cell Lung Cancer.
复制标题

个人和预后:非小细胞肺癌放射治疗反应的组织和液体生物标记物。

DOI:
10.1016/j.semradonc.2020.11.002
复制
发表时间:
2021-04
影响因子:
3.5
通讯作者:
Kao, Gary D.
Kao, Gary D.
中科院分区:
医学2区
文献类型:
--
作者:
Jean-Baptiste, Samuel R.;Feigenberg, Steven J.;Dorsey, Jay F.;Kao, Gary D.

文献摘要

参考文献

相似文献

最近的治疗进展改善了非小细胞肺癌(NSCLC)患者的预后,通常利用肿瘤分子特征来识别靶向突变。“液体活组织检查”的进步进一步加强了这一点,即使用外周血对肿瘤生物学进行非侵入性的连续采样。虽然肿瘤基因组的改变已经确立了转移性非小细胞肺癌的治疗意义,但也在研究开发组织和液体生物标记物在早期疾病中的应用,例如早期患者接受放射治疗或局部非小细胞肺癌。
Recent treatment advances have improved outcomes for patients with non-small cell lung cancer (NSCLC), often utilizing tumor molecular characterization to identify targetable mutations. This is further enhanced by advancements in “liquid biopsies”, using peripheral blood for noninvasive, serial sampling of tumor biology. While tumor genomic alterations have established therapeutic implications in metastatic NSCLC, research is also ongoing to develop applications for tissue and liquid biomarkers in earlier stage disease, such as patients treated with radiation for early stage or locoregional NSCLC.
DOI: 10.21873/invivo.11645
发表时间: 2019-09-01
期刊: IN VIVO
影响因子: 2.3
作者:
Choi, Se Young;Lim, Bumjin;Kim, Choung-Soo
通讯作者: Kim, Choung-Soo
DOI: 10.1038/nature22364
发表时间: 2017-04-26
期刊: Nature
影响因子: 64.8
作者:
Abbosh C;Birkbak NJ;Wilson GA;Jamal-Hanjani M;Constantin T;Salari R;Le Quesne J;Moore DA;Veeriah S;Rosenthal R;Marafioti T;Kirkizlar E;Watkins TBK;McGranahan N;Ward S;Martinson L;Riley J;Fraioli F;Al Bakir M;Grönroos E;Zambrana F;Endozo R;Bi WL;Fennessy FM;Sponer N;Johnson D;Laycock J;Shafi S;Czyzewska-Khan J;Rowan A;Chambers T;Matthews N;Turajlic S;Hiley C;Lee SM;Forster MD;Ahmad T;Falzon M;Borg E;Lawrence D;Hayward M;Kolvekar S;Panagiotopoulos N;Janes SM;Thakrar R;Ahmed A;Blackhall F;Summers Y;Hafez D;Naik A;Ganguly A;Kareht S;Shah R;Joseph L;Marie Quinn A;Crosbie PA;Naidu B;Middleton G;Langman G;Trotter S;Nicolson M;Remmen H;Kerr K;Chetty M;Gomersall L;Fennell DA;Nakas A;Rathinam S;Anand G;Khan S;Russell P;Ezhil V;Ismail B;Irvin-Sellers M;Prakash V;Lester JF;Kornaszewska M;Attanoos R;Adams H;Davies H;Oukrif D;Akarca AU;Hartley JA;Lowe HL;Lock S;Iles N;Bell H;Ngai Y;Elgar G;Szallasi Z;Schwarz RF;Herrero J;Stewart A;Quezada SA;Peggs KS;Van Loo P;Dive C;Lin CJ;Rabinowitz M;Aerts HJWL;Hackshaw A;Shaw JA;Zimmermann BG;TRACERx consortium;PEACE consortium;Swanton C
通讯作者: Swanton C
DOI: 10.1073/pnas.0710370104
发表时间: 2007-12-26
影响因子: 11.1
作者:
Bean, James;Brennan, Cameron;Pao, William
通讯作者: Pao, William
DOI: 10.18632/oncotarget.25053
发表时间: 2018-04-10
期刊: Oncotarget
影响因子: --
作者:
Kageyama SI;Nihei K;Karasawa K;Sawada T;Koizumi F;Yamaguchi S;Kato S;Hojo H;Motegi A;Tsuchihara K;Akimoto T
通讯作者: Akimoto T
DOI: 10.1056/nejmoa1809697
发表时间: 2018-12-13
影响因子: 158.5
作者:
Antonia, S. J.;Villegas, A.;Ozguroglu, M.
通讯作者: Ozguroglu, M.